ACTB and cholangiocarcinoma: We found a significant increase (p = 0.043, Mann–Whitney test) of DUSP4 protein levels relative to β-actin in the 7 KRAS mutated cholangiocarcinoma cell lines when compared to KRAS wildtype CCA cell lines (Fig. 7).